Search research articles
Contact Us
Filters
Showing results (21-30 of 71) with videos related to
Page
of 8
Sort By:
Psychological Reports
|
November 26, 2009
Alexithymia is positively associated with the outcome of in vitro fertilization (IVF) treatment
D Kakatsaki, G Vaslamatzis, M Chatziandreou, et al.
Bioelectromagnetics
|
January 1, 1994
Sleep inducing effect of low energy emission therapy
M Reite, L Higgs, J P Lebet, et al.
Annals of Biomedical Engineering
|
May 1, 1996
Electroencephalographic changes following low energy emission therapy
J P Lebet, A Barbault, C Rossel, et al.
Journal of Neurovirology
|
June 1, 1997
Stable neurological function in subjects treated with 2'3'-dideoxyinosine
J J Sidtis, U Dafni, P Slasor, et al.
Anticancer Research
|
January 25, 2008
A randomized trial to compare the efficacy and safety of antiemetic treatment with ondansetron and ondansetron zydis in patients with breast cancer treated with high-dose epirubicin
D Pectasides, U Dafni, G Aravantinos, et al.
Neurology
|
July 23, 1998
A phase I/II trial of nimodipine for HIV-related neurologic complications
B A Navia, U Dafni, D Simpson, et al.
Anticancer Research
|
August 5, 2003
CRD-BP: a c-Myc mRNA stabilizing protein with an oncofetal pattern of expression
P Ioannidis, L Mahaira, A Papadopoulou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 28, 2004
A prospective study on lung toxicity in patients treated with gemcitabine and carboplatin: clinical, radiological and functional assessment
I Dimopoulou, E Efstathiou, A Samakovli, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 22, 2020
Efficacy of cancer vaccines in selected gynaecological breast and ovarian cancers: A 20-year systematic review and meta-analysis
U Dafni, S Martín-Lluesma, K Balint, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 31, 2015
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)
N I Cherny, R Sullivan, U Dafni, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 71) with videos related to
Sort By:
Page
of 8
Psychological Reports
|
November 26, 2009
Alexithymia is positively associated with the outcome of in vitro fertilization (IVF) treatment
D Kakatsaki, G Vaslamatzis, M Chatziandreou, et al.
Bioelectromagnetics
|
January 1, 1994
Sleep inducing effect of low energy emission therapy
M Reite, L Higgs, J P Lebet, et al.
Annals of Biomedical Engineering
|
May 1, 1996
Electroencephalographic changes following low energy emission therapy
J P Lebet, A Barbault, C Rossel, et al.
Journal of Neurovirology
|
June 1, 1997
Stable neurological function in subjects treated with 2'3'-dideoxyinosine
J J Sidtis, U Dafni, P Slasor, et al.
Anticancer Research
|
January 25, 2008
A randomized trial to compare the efficacy and safety of antiemetic treatment with ondansetron and ondansetron zydis in patients with breast cancer treated with high-dose epirubicin
D Pectasides, U Dafni, G Aravantinos, et al.
Neurology
|
July 23, 1998
A phase I/II trial of nimodipine for HIV-related neurologic complications
B A Navia, U Dafni, D Simpson, et al.
Anticancer Research
|
August 5, 2003
CRD-BP: a c-Myc mRNA stabilizing protein with an oncofetal pattern of expression
P Ioannidis, L Mahaira, A Papadopoulou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 28, 2004
A prospective study on lung toxicity in patients treated with gemcitabine and carboplatin: clinical, radiological and functional assessment
I Dimopoulou, E Efstathiou, A Samakovli, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 22, 2020
Efficacy of cancer vaccines in selected gynaecological breast and ovarian cancers: A 20-year systematic review and meta-analysis
U Dafni, S Martín-Lluesma, K Balint, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 31, 2015
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)
N I Cherny, R Sullivan, U Dafni, et al.
Page
of 8